Lotegate Eye Drop is a combination ophthalmic solution containing Gatifloxacin 3 mg and Loteprednol etabonate 5 mg, formulated for the treatment of bacterial ocular infections accompanied by inflammation. Gatifloxacin, a fourth-generation fluoroquinolone antibiotic, exhibits broad-spectrum bactericidal activity by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication and promoting rapid eradication of susceptible pathogens. Loteprednol etabonate, a corticosteroid with potent anti-inflammatory properties, acts by modulating the inflammatory response through inhibition of multiple inflammatory mediators, reducing ocular redness, swelling, and discomfort. This dual-action formulation is indicated for bacterial conjunctivitis, keratitis, and other ocular surface infections where inflammation is present. Lotegate Eye Drop should be administered as directed by a healthcare professional, typically instilled into the affected eye(s) multiple times daily for the prescribed duration. Caution is advised in patients with known hypersensitivity to fluoroquinolones or corticosteroids, and prolonged use should be monitored to prevent potential adverse effects such as increased intraocular pressure or secondary infections. This combination therapy offers an effective approach to managing infectious ocular conditions while simultaneously controlling associated inflammatory symptoms, promoting faster recovery and improved patient comfort.